Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma
- PMID: 34493238
- PMCID: PMC8424899
- DOI: 10.1186/s12885-021-08699-3
Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma
Abstract
Background: The copper metabolism MURR1 domain (COMMD) protein family involved in tumor development and progression in several types of human cancer, but little is known about the function of COMMD proteins in hepatocellular carcinoma (HCC).
Methods: The ONCOMINE and the UALCAN databases were used to evaluate the expression of COMMD1-10 in HCC and the association of this family with individual cancer stage and tumor grade. Kaplan-Meier (K-M) Plotter and Cox analysis hint the prognostic value of COMMDs. A network comprising 50 most similar genes and COMMD1-10 was constructed with the STRING database. Gene set enrichment analysis (GSEA) was performed using LinkedOmics database. The correlations between COMMD expression and the presence of immune infiltrating cells were also analyzed by the tumor immune estimation resource (TIMER) database. GSE14520 dataset and 80 HCC patients were used to validated the expression and survival value of COMMD3. Human HCC cell lines were also used for validating the function of COMMD3.
Results: The expression of all COMMD family members showed higher expression in HCC tissues than that in normal tissues, and is associated with clinical cancer stage and pathological tumor grade. In HCC patients, the transcriptional levels of COMMD1/4 are positively correlated with overall survival (OS), while those of COMMD2/3/7/8/9 are negatively correlated with OS. Multivariate analysis indicated that a high level of COMMD3 mRNA is an independent prognostic factor for shorter OS in HCC patients. However, the subset of patients with grade 3 HCC, K-M survival curves revealed that high COMMD3/5/7/8/9 expression and low COMMD4/10 expression were associated with shorter OS. In addition, the expression of COMMD2/3/10 was associated with tumor-induced immune response activation and immune infiltration in HCC. The expression of COMMD3 from GSE14520 dataset and 80 patients are both higher in tumor than that in normal tissue, and a higher level of COMMD3 mRNA is associated with shorter OS. Knockdown of COMMD3 inhibits human HCC cell lines proliferation in vitro.
Conclusions: Our study indicates that COMMD3 is an independent prognostic biomarker for the survival of HCC patients. COMMD3 supports the proliferation of HCC cells and contributes to the poor OS in HCC patients.
Keywords: COMMD protein family; Hepatocellular carcinoma; Immune infiltration; Prognosis; Transcription; mRNA.
© 2021. The Author(s).
Conflict of interest statement
The authors declared that they have no competing interests.
Figures
Similar articles
-
High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients.Dis Markers. 2021 Aug 17;2021:9971799. doi: 10.1155/2021/9971799. eCollection 2021. Dis Markers. 2021. PMID: 34457090 Free PMC article.
-
Investigating the Association between COMMD3 Expression and the Prognosis of Hepatocellular Carcinoma.J Cancer. 2022 Mar 21;13(6):1871-1881. doi: 10.7150/jca.62454. eCollection 2022. J Cancer. 2022. PMID: 35399735 Free PMC article.
-
Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.Dig Dis Sci. 2022 Jan;67(1):146-158. doi: 10.1007/s10620-021-06832-7. Epub 2021 Jan 26. Dig Dis Sci. 2022. PMID: 33495920 Free PMC article.
-
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.Eur J Cancer. 2012 Oct;48(15):2328-38. doi: 10.1016/j.ejca.2012.03.001. Epub 2012 Mar 27. Eur J Cancer. 2012. PMID: 22459764 Free PMC article. Review.
-
PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review).Int J Oncol. 2024 Nov;65(5):109. doi: 10.3892/ijo.2024.5697. Epub 2024 Sep 27. Int J Oncol. 2024. PMID: 39329206 Free PMC article. Review.
Cited by
-
Commander Complex-A Multifaceted Operator in Intracellular Signaling and Cargo.Cells. 2021 Dec 7;10(12):3447. doi: 10.3390/cells10123447. Cells. 2021. PMID: 34943955 Free PMC article. Review.
-
Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.Cancer Med. 2023 May;12(10):11941-11959. doi: 10.1002/cam4.5320. Epub 2022 Oct 7. Cancer Med. 2023. PMID: 36205192 Free PMC article.
-
COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma.Front Pharmacol. 2022 Sep 30;13:974107. doi: 10.3389/fphar.2022.974107. eCollection 2022. Front Pharmacol. 2022. PMID: 36249824 Free PMC article.
-
COMMD3 Expression Affects Angiogenesis through the HIF1α/VEGF/NF-κB Signaling Pathway in Hepatocellular Carcinoma In Vitro and In Vivo.Oxid Med Cell Longev. 2022 Sep 2;2022:1655502. doi: 10.1155/2022/1655502. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36092163 Free PMC article.
-
Structure and interactions of the endogenous human Commander complex.Nat Struct Mol Biol. 2024 Jun;31(6):925-938. doi: 10.1038/s41594-024-01246-1. Epub 2024 Mar 8. Nat Struct Mol Biol. 2024. PMID: 38459129 Free PMC article.
References
-
- Collaborators GMaCoD Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- 81570587, 81700557 and 81902244/National Natural Science Foundation of China
- 2013A061401007 and 2017B030314018/the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology
- 2015A030308010/Guangdong Provincial Natural Science Funds for Major Basic Science Culture Project
- 201704020150/Science and Technology Program of Guangzhou
- 2016A030310141 and 2020A1515010091/Natural Science Foundations of Guangdong province
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases